Skip to search formSkip to main contentSkip to account menu

Alternate census tract at cancer XXX Dx:ID:Pt:^Patient:Nom

Known as: Alternate census tract at cancer Dx, Area censuaria alternata alla Dx di cancro XXX:ID:Pt:^Paziente:Nom, ALTERNATE CENSUS TRACT AT CANCER XXX DX:intradérmico:punto en el tiempo:^paciente:Nominal 
National Institutes of Health

Related topics

Related topics

3 relations
IdentifierNomPatients

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Does integration of Magee equations into routine clinical practice affect whether oncologists order the Oncotype DX test? A prospective randomized trial
OBJECTIVE The three Magee Equations provide an estimate of the Oncotype DX recurrence score using commonly available… 
2018
2018
Abstract P4-12-11: Cost effectiveness of oncotype Dx for early stage breast cancer under National health insurance
Background : Oncotype Dx is being used increasingly for risk stratification to identify for patients with estrogen receptor… 
Review
2018
Review
2018
Uptake of BRCA 1/2 and oncotype DX testing by medical and surgical oncologists
PurposeThe diffusion of genomic testing is critical to the success of precision medicine, but there is limited information on… 
2018
2018
Pathologist's health‐care value in the triage of Oncotype DX® testing: a value‐based pathology study of tumour biology with outcomes
Pathologists provide expert tissue assessment of breast cancer, yet their value to guide the appropriate use of breast cancer… 
2018
2018
Panorama da ovinocultura e da caprinocultura a partir do Censo Agropecuário 2017.
A importância economica da agropecuaria traz um crescente interesse no acompanhamento dos seus resultados, pela analise do… 
2018
2018
Predicting Oncotype DX scores using clinicopathologic features: A report from the National Cancer Database.
551Background: The Oncotype DX recurrence score is used to predict the benefits of chemotherapy added to adjuvant hormone therapy… 
Review
2014
Review
2014
Factors influencing Oncotype DX use in the management of early breast cancer: a single centre experience.
Review
2011
Review
2011
P1-10-05: Is the 21-Gene Breast Cancer Test (Oncotype DX®) Cost-Effective?
Background: The Oncotype DX® Breast Cancer Test is a validated 21-gene assay that predicts 10 year risk of recurrence and the… 
2009
2009
Clinical roundtable monograph: a multidisciplinary approach to the use of oncotype DX in clinical practice.
Recently, recommendations for the use of the Oncotype DX assay in estrogen receptor-positive node-negative breast cancer patients… 
2003
2003
SENSOS E DISSENSOS: AS INOVAÇÕES METODOLÓGICAS DO CENSO DEMOGRÁFICO 2000
O ensaio analisa as implicacoes das mudancas merodologicas do Censo Demognifico 2000 para a pesquisa sobre a evolucao… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)